Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Nobelpharma Co., Ltd.

Status and phase: Completed; Phase 3

Conditions: Wison's Disease

Treatments: Drug: Zinc acetate

Study type: Interventional

Funder types: Industry

Identifiers

NCT00212368

NPC-02-1

Details and patient eligibility

About

The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Sex: All

Ages: 1+ year old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Wilson's disease(adult,infant,pregnant woman)

Exclusion criteria

• acute hepatitis
• malignant tumor

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)